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Abstract
Background: Childhood vaccination remains a primary mechanism for reducing the burden of infectious disease.
In the United Kingdom, as in many countries, a sustained effort is required to ensure that vaccination targets are
met to afford protection to the whole population from vaccine preventable disease. The Celebrate and Protect
programme is a collaborative partnership developed to improve the uptake of childhood vaccination across a
number of boroughs within London through the use of a celebration card to encourage attendance for vaccination
and enhance relationships between general practices and the parents/carers of children.
Methods: This study was undertaken to assess the suitability, feasibility and acceptability of the Celebrate and
Protect programme across nine boroughs in London. Data were collected either from telephone interviews (n = 24)
or from focus groups (n = 31). A total of 55 key informants were included in the study, representing strategic,
commissioning or policy leads, healthcare professionals and primary care teams delivering vaccinations and
parents/carers of children under five.
Results: The analysis of data identified that whilst parents/carers saw the celebration card positively this raised the
issue of ‘vaccine hesitancy’ and the lack of information that parents/carers have to make informed decisions about
vaccination. Similarly, healthcare professionals viewed the programme positively and felt that it was deliverable
within existing resources although they raised wider questions about on-going sustainability and about quantitative
data collection. In relation to the collaboration between primary care and a pharmaceutical company in developing
the Celebrate and Protect programme, it was generally felt that, provided appropriate governance is in place, it was
a pragmatic approach in which the benefits outweighed any perceived disadvantages.
Discussion: The Celebrate and Protect programme was seen as an innovative collaborative programme to engage
with parents and carers of children in order to improve relationships between service users and providers and
subsequently increase vaccination uptake. The analysis demonstrates that that the celebration card is suitable for its
purpose, acceptable to both healthcare professionals and to parents/carers of children and the Celebrate and
Protect programme has been able to deliver its aims.
Conclusion: Whilst the delivery of the ‘celebration card’ intervention in primary met its objectives there are some
outstanding issues in terms of the sustainability of the initiative and the ability to demonstrate quantitative
improvements in vaccination uptake rates.
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Background
Vaccination in the UK
Vaccination is a public health intervention that has dem-
onstrably reduced the global burden of infectious disease
and which can, through comprehensive coverage, reduce
health inequalities [1]. There are three main types of
vaccination: childhood vaccination, adult vaccination
and travel vaccination. Childhood vaccination results in
individual immunisation against a range of diseases but
also provides a level of indirect protection to the com-
munity when uptake is sufficiently high [2]. In the UK,
childhood vaccinations are administered by General
Practitioners (GPs), with uptake on a voluntary basis [3].
Timings of vaccinations have been set according the na-
tional schedule produced by the Department of Health
(DH) informed by the age-specific risk for a disease, abil-
ity to respond to the vaccination and likelihood of devel-
oping complications [4].
Current estimates suggest that childhood vaccination
coverage needs to reach 95 % to ensure herd immunity,
a standard adopted by the World Health Organisation
(WHO) [5]. Historically, immunisation uptake in London
is variable and despite recent improvements many areas
still perform below this target. With more than 350,000
children under the age of 5 eligible for vaccination in a
single year (366,715 in 2010–11) ensuring 95 % of this
population is vaccinated remains a logistical challenge.
Data on the administration of vaccinations in primary care
are recorded within the Child Health Information System
[6]. These data are subsequently collated centrally to
Cover of Vaccination Evaluated Rapidly (COVER), a na-
tional programme now managed by Public Health Eng-
land (PHE), which gathers vaccination uptake data based
on cohorts of children aged 12, 24 months and 5 years [7].
Despite the emphasis of both national and local public
health programmes on ensuring the delivery of vaccines
there is a wide geographical variation in uptake with
some regions of England achieving less than 80 % cover-
age and other areas achieving 95 % or above [8]. In
addition to the geographical variation many vaccination
programmes demonstrate temporal variation. The most
dramatic example has been with the Measles-Mumps-
Rubella (MMR) vaccination, with a reduction to less
than 80 % national coverage in 2003–4 associated with
concerns about the safety of the vaccine which have
since been discredited [9].
Theoretical perspectives on vaccination uptake
Decision making by parents/carers plays an extremely
important role in the immunisation process as the be-
liefs of parents/carers have been shown to strongly influ-
ence resulting vaccination of their child. These parents/
carer beliefs and associated actions around vaccination
can be classified as follows [10]:
 “Accepters”—those who believe in vaccination and
actively seek to vaccinate their children;
 “Vaccine-hesitant”—those who accept vaccination
but have significant concerns about vaccinating their
children;
 “Late vaccinators”—those who purposely delay
vaccinating or choose only some vaccines;
 “Rejecters”—those who completely reject vaccination.
It has been proposed that these typologies represent a
continuum or spectrum of acceptance, from active de-
mand for vaccines to complete refusal of all vaccines
[11]. Benin et al. (2006) also identified a number of bar-
riers to vaccination and some potential enablers or pro-
moters [10]. Barriers included poor relationships with
healthcare professionals resulting in a lack of trust,
which may coincide with a strong trusting relationship
with someone opposed to vaccination such as friends,
family or other parents/carers. Of course this was often
coupled with anxieties about the side effects of vaccines
or a belief that herd immunity would protect their child.
Some of the promoters of vaccination included good re-
lationships with healthcare professionals that fostered
trust and an open dialogue about vaccinations, and
recognition that parents/carers may want to adhere to
social/cultural norms by vaccinating. Those classified as
“vaccine hesitant” or “late vaccinators” often have a
broad range of reasons and rationales for their hesitancy
to engage with vaccination, and an equally diverse range
of external influences that may ‘nudge’ parents/carers
along the continuum in either direction.
A conceptual model that encompasses many of the
historical, political and socio-cultural factors that influ-
ence hesitancy, all of which are underpinned by trust
influences, is shown in Fig. 1 [11].
Interventions to improve vaccination uptake
A number of strategies have been developed that aim to
target parents/carers to improve vaccination coverage,
from simple strategies such as sending reminder letters/
cards to more complex and costly strategies such as
home visiting or involving school nurse teams [12, 13].
A recent systematic review demonstrated that ‘reminder
and recall’ systems are an effective way of improving
immunisation rates, although the development of locally
appropriate systems is recommended [14]. Whilst initia-
tives included in the review have demonstrated some
impact on vaccination, this is dependent on good sys-
tems of data collection/reporting and communication
between systems and agencies to ensure timely and
targeted activity. Furthermore, there is recognition that
specific black and minority ethnic (BME) groups are
often underrepresented in vaccination services, alongside
those patients not registered with GPs [15].
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It is clear that there is a need to develop effective pro-
grammes, based on theory, that can improve vaccination
rates through engagement with parents and acting as an
effective ‘reminder and recall’. In addition it may be
necessary to remind patients why children need vaccin-
ation and as such these activities can be combined as a
‘call to action’.
This paper briefly describes an intervention that was de-
veloped as a ‘call to action’ to improve the uptake of child-
hood vaccinations in some areas of London. The paper
also aims to provide a qualitative evaluation to assess the
feasibility, suitability and acceptability of the delivery of
the intervention by identifying specific barriers and facili-
tators to delivering the programme and to provide some
suggestions for learning in future programmes.
Methods
This section briefly describes the programme that was
delivered but focuses on describing the methodological
approach to undertaking a qualitative evaluation to
assess the feasibility, suitability and acceptability of the
programme from the perspectives of parents/carers,
health care practitioners and policy makers.
The celebrate and protect programme—a communication
intervention
NHS Barking and Dagenham, a Primary Care Trust
(PCT),1 in partnership with Sanofi Pasteur MSD
(SPMSD), a vaccine manufacturer, developed the Cele-
brate and Protect programme in 2012. The initiative was
part of a wider Olympic and Paralympic Host Borough
health legacy programme linked to the London 2012
Olympic Games. The programme aimed to increase up-
take of childhood vaccination by supplementing current
General Practitioner (GP) practices’ current call/recall
activities and through improved engagement between
families and GP practices. The intervention consisted of
a celebration card and immunisation schedule sent out
by the GP practice staff to families of children before
their vaccination was scheduled. The celebration card
Fig. 1 A conceptual model that encompasses many of the historical, political and socio-cultural factors that influence the position of parents/
carers on the hesitancy continuum, all of which are underpinned by trust [11]
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was intended to act as a ‘call to action’ for the parents/
carers of children under five to attend an initial 6–8
week check (new-borns) and vaccination appointments
(1 year olds and 4 year olds) with their GP practice.
The first wave of the programme was initiated in July
2012 in nine London PCTs: Barking & Dagenham,
Bexley, Greenwich, Kensington & Chelsea, Hammersmith
& Fulham, Newham, Tower Hamlets, Waltham Forest
and Westminster. Part of the scope of the initial wave was
to assess the feasibility and acceptability of the programme
through engaging with a range of stakeholders and itera-
tive development of the intervention to allow a tailored
rollout across additional PCTs in London and possibly fur-
ther afield. During the first wave, practices across the
PCTs were contacted and asked to participate with the
aim of engaging 50 % of practices. Across the nine PCTs,
66.3 % (n = 177) of GP practices were recruited, ranging
from 42 to 100 % of practices within the PCTs.
A personalised celebration card and an information
leaflet with a vaccination schedule was co-designed with
parents/carers. Workshops were held with parents/
carers of children to assess the response to the design of
the cards, which included a central character and the in-
clusion of landmarks from east and central London asso-
ciated with the Olympic and Paralympic games. In
addition, the celebration cards included a statement on
the back regarding partnership between the NHS and
Sanofi Pasteur MSD.
Following training sessions for practice nurses and
managers, the celebration cards were delivered to par-
ticipating practices. The programme management team
arranged for an appropriate number of celebration cards
and pre-franked (second class postage) envelopes to be
dispatched to the individual GP practices according to
the number of registered children within each cohort,
plus a 5 % uplift. The cards were subsequently sent out
by the GP practice to parents/carers registered at the
practice following the birth of a child or prior to the first
or fourth birthday of a child registered at the practice.
The card intended to celebrate the birth of a child or a
child’s birthday and act as a ‘call to action’ for the par-
ent/carers to contact the practice and book a health
check or vaccination.
The card for new-borns included a message inviting
parents/carers to make an appointment with the prac-
tice to come and discuss any questions they had about
the baby’s health and for the baby to be examined, at
which time it is usual for babies to receive their first set
of vaccinations. Cards distributed within PCTs that had
a universal tuberculosis (TB) vaccination programme
(i.e. where the incidence of TB is greater than 40/
100,000 population) included an additional message for
parents/carers to make an appointment for TB vaccin-
ation [16].
Birthday cards for 1 year olds included a message that
the child’s vaccinations were due and an invitation to
contact the GP practice to make an appointment. Birth-
day cards sent to the 4 year olds also had a message to
contact their GP practice to make an appointment.
However, this card was only sent to those children who
had not yet received their immunisations, so this card
acted as a failsafe. The cards also contained information
signposting parents/carers to the ‘Red Book’, the Per-
sonal Child Health Record which is a national standard
health and development record given to parents/carers
at a child’s birth, and www.immunisation.nhs.uk, along
with an insert with information about the schedule of
vaccination as recommended by the DH.
Participants
Sample groups were identified to include stakeholders at
three different levels (Table 1):
Group one—policymakers (n = 15): this included
strategic, commissioning or policy leads along with the
programme management team, a purposive sample
identified from the broader stakeholder group.
Group two—practitioners (n = 9): primary care staff
were recruited by canvassing 40 (23 %) GP practices
involved in wave one via emails from the PCT
immunisation co-ordinators.
Group three—parents/carers of children under five
(n = 31): participants were recruited via the PCT
immunisation co-ordinators with the aim of identifying
2–3 participants from each PCT, although respondents
were affiliated to just six of the nine PCTs involved in the
Celebrate and Protect programme. Whilst the sample
was not specifically designed to be representative the
participants were of diverse ethnic and socio-economic
backgrounds.
Data collection
Semi-structured telephone interviews were undertaken
with all participants in groups one and two by a member
Table 1 Outline of participants included in the qualitative study
Group Data
collection
Grouping Participants
1 Telephone
interviews
Policy makers Immunisation co-ordinators
(n = 5), public health consultants
(n = 3), senior public health
managers (n = 5) & industry
stakeholders (n = 2)
2 Telephone
interviews
Practitioners Participants included administrators
(n= 2), managers (n= 4), GP (n= 1)
and nursing staff (n= 2)
3 Focus
Groups
Parents/carers
of children
under 5
Parents/carers (n = 31)
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of the evaluation team. The rationale for this was simply
pragmatic; to attempt to bring individuals together from
across London is resource intensive. In addition, undertak-
ing telephone interviews was preferable for the research
participants as this provided a flexible mechanism for them
to contribute where they may have declined involvement
had they be asked to attend a meeting in person. Focus
groups were selected as the most appropriate data collec-
tion methods for parents and carers to include as many
views as possible but with limited available resources.
A total of three focus groups were conducted in three
locations: east, south east and north west London be-
tween October 2012 and February 2013 with 3, 10 and
18 participants respectively. A member of the evaluation
team facilitated the focus groups and a topic guide led
discussions. Proceedings from the focus groups and in-
terviews were audio-recorded where possible (with the
consent of participants), transcribed by a project admin-
istrator and validated by two evaluation team members.
Oral consent was requested and recorded from each par-
ticipant for both telephone-interviews and focus groups.
Analysis
Transcripts and field notes from all interviews and focus
groups were analysed thematically by a member of the
evaluation team using the Johnson and Sholes (2005)
suitability, feasibility and acceptability framework [17].
Suitability is defined as the rationale for developing a
particular strategy and whether this strategy supports
the organisational or programme aims; feasibility relates
to the availability of organisational or programmatic re-
sources, skills and competencies to deliver a particular
strategy; and acceptability describes the reaction of
stakeholders and the likelihood of encountering poten-
tial organisational or programmatic risks [17]. The re-
searcher that undertook the data collection (NT) is a
female pharmacist with a PhD. The researchers that ana-
lysed the data are female (SL) and male (SG) and are
public health practitioners and researchers, respectively,
both with master degrees and completing their doctor of
public health qualifications. All have performed research
studies including focus group and interview in previous
studies.
Results
Suitability
The Celebrate and Protect programme aimed to improve
the uptake of immunisation services by parents/carers in
order to increase vaccination coverage in those areas of
London where the programme was delivered. It was also
developed to encourage parents/carers receiving the
celebration cards to proactively engage with their GP
practices in scheduling vaccination for their children.
Understanding how parents/carers perceived the cards
and their intended action was important to validate the
mechanism. Responses from the focus groups (and some
providers) indicated that the participants’ perceptions of
the celebration cards were more of a reminder than a
‘call to action’. This may be explained by the fact that
some parents/carers may already have received a letter
from their GP reminding them the time to immunise
the children was due and the card, in this instance,
could be seen as an additional reminder.
Participants in the focus groups were asked to com-
ment on the content of the celebration cards, and
whether sufficient information was presented to allow
them to take the necessary action. Some participants felt
not enough information was provided about why vaccin-
ation was necessary and the timing of steps that were
needed to vaccinate their child. Many parents/carers felt
that this information was necessary to allay their anxie-
ties or fears where there were reservations regarding
immunisation. This was countered somewhat by the in-
clusion of scheduling information provided on an insert
to be included with the cards. Parents/carers felt the
content was likely to be effective in prompting action
amongst people not opposed to immunisation, although
it would be less effective with those opposed to getting
their children immunised.
“…There’s nothing on here to say why you should have
your baby immunised…” “…Quite dry information, it
just gives you the name of the inoculation. I’m not a
doctor… Haemophilus influenzae Type B, what does
that protect my baby with…?” (Group 3-parents/carers).
On the other hand, it was apparent that without including
more direct information regarding what actions parents/
carers need to take on receiving the card, there would be a
risk of parents/carers perceiving the card as a good ges-
ture from practices as opposed to a call for action.
“…I think it’s a very good idea and it’s wonderful,
however…I’d presume.... it’s just a card, a
congratulation card…” (Group 3-parents/carers).
Focus group participants made suggestions on how
the cards could be improved in a way that could poten-
tially sway the minds of those opposed to immunisation:
“…put a little bit maybe on the back of there and say,
well we could give hemacoccal [sic] against
meningitis…” “…I think …explain what some of the
diseases that immunisation is trying to protect
against…” (Group 3-parents/carers).
Participants felt adding a link to credible website
would be invaluable:
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“…link, with the added recommendation that you can
call your healthcare professional via telephone on the
card....”. Or add that “…If you have any questions or
concerns please come along or give us a ring…”
because “…just think it gives leeway for people who
feel a bit insecure and nervous, sort of isolated; it just
makes it more robust…the information… it’s not just a
reminder…you know, if you have any concerns, we’ll
be happy to speak with you…” (Group 3-parents/
carers).
And as one of the parents/carers mentioned:
“… although I always had the intention to keep up
with all the immunisation, I was always a little bit
sceptical and worried about immunisation…I would
like to be more informed about the [unclear] side
effects of the immunisation…” (Group 3-parents/carers).
Aside from comments on the contents of the card the
focus groups discussions also addressed the desirability
or potential demand for the cards, indicating that if they
missed out on the celebration card many of the parents/
carers would feel offended or excluded. From the
provider perspective, the cards also seemed to be very
popular, evidenced by the ability to recruit additional
PCTs for subsequent waves of the Celebrate and
Protect programme: ‘[Celebrate and Protect] Impressive…’
…12 boroughs [PCTs] signed up.... 175 practices
registered…definitely a starting point…can only go up....
parents more aware of imm[unisations]…” (Group 1-
policymakers).
Also retention rates of the PCTs in subsequent
phases were suggestive of the perceived effectiveness
and popularity of the programme with two thirds
continuing to be involved in the second phase, which
covered an additional three PCTs. Nevertheless,
responses from some strategic leads indicated that at a
practice level there were notable variations in
engagement:
“…there are practice variances - with some with total
buy in and some that do not want to know/do not
want any extra workload” (Group 1-policymakers).
Understanding the perceived added value of the
Celebrate and Protect programme was also important
to encourage future engagement. Some participants,
especially from the strategic leads and providers
groups expressed the opinion that celebration cards
played a necessary role in helping to communicate an
issue that is otherwise delicate or difficult to broker
with some parents/carers. They felt that celebration
cards offered a suitable alternative:
“…Celebrate and Protect supports communication…it
makes things easier…” Moreover, in their experiences,
“…mothers are reluctant to go to practices (for
vaccination) unless invited as they feel surgeries are
busy” and “do not like letters that sound threatening”
(Group 1-policymakers).
Additionally some providers felt that the Celebrate
and Protect programme added value to the call/recall
system and was of particular value to practices without a
robust call/recall system:
“…we were in bottom 10, since Celebrate and Protect,
we are now in top 10…” (Group 2-practitioners).
Practices that had an established call/recall system also
noted the added value:
“… get [Celebrate and Protect] people up to date with
vaccinations… going fine, actually…asked a couple of
parents.... those asked said…reminded me to come…
very happy…”“…Celebrate and Protect good for
‘impetus’ to start thinking about immunisation but
need other basic processes in place, e.g. good call and
recall system in practice and at PCT level; follow ups
of defaulters; need for more ‘support processes…”
(Group 2-practitioners).
Some providers however did not perceive the Cele-
brate and Protect programme as adjunct to a call/recall
system but a substitute:
“…Celebrate and Protect.... birthday cards have
lessened my workload…don’t have to make phone
calls.... surgery does not have to pay for postage....
reduced workload as do not have to speak to address
concerns…” (Group 2-practitioners).
Some parents/carers who had good existing relation-
ships with their practices didn’t see any added value to
the card:
“…Well I…I don’t really need because I have …the
Red Book…my doctor rang me and sent a text, so I
get reminded all the time”. “I still think it’s a
really good idea… (but)… a letter would be better
I wouldn’t need a pretty card” (Group 3-parents/
carers).
Others who didn’t have existing relationships with
their practice felt that the card would be more help-
ful but were keen to stress that the programme
should not be an alternative to the current call/recall
system:
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“… I think you can’t take away from people, like face
to face or call…”“…and if then they (mothers) say no
then they can actually talk to them about the reason,
so you’re addressing…any other issues that they might
have…” (Group 3-parents/carers).
Feasibility
Responses from the strategic leads indicated that the
Celebrate and Protect programme was made possible by
the involvement of immunisation leads linked to PCTs
that had historically established trust with GP practices.
The leads were encouraged to facilitate implementation
through communication and provision of training and
training materials to GP practices.
“… (Leads) were able to secure commitment from GP
practices - as they have already established trust/good
relationship with GP practices, so much easier to get
GP buy-in to the project…” (Group 1-policymakers).
Some providers explained that implementation of the
Celebrate and Protect programme didn’t require add-
itional resources:
“[we did] not needed any support from lead PCT for
Celebrate and Protect all very straightforward…with
information pack…useful guide on how to do labels....”
“.... working fine…not much extra work per month....”
(Group 2-practitioners).
If anything, some practices felt the Celebrate and Pro-
tect programme gave them the additional resources to
support their work:
“…before that (Celebrate and Protect) it was just me …
Celebrate and Protect added boost…” “…it’s not a big
job to do…an hour a month…” (Group 2-
practitioners).
Strategically however, there was a perceived need to
secure commitment from an organisation to take a
lead role (e.g. NHS London), because, thus far, the
programme was largely driven by individuals, with a
risk to its sustainability in the face of the imminent
NHS structural changes.
“…Celebrate and Protect is driven by power of
personality, not supported by system....” (Group
1-policymakers).
Many of the strategic leads felt that the Celebrate and
Protect programme was a low cost initiative with an im-
plementation strategy that could allow roll-out across
other areas on both a local and national scale.
Participants felt the programme was financially viable,
especially for practices falling short of their target of
95 % coverage.
Particular challenges around the ability to develop the
evidence of the impact of the Celebrate and Protect
programme were clear from responses from providers
and strategic leads. Some respondents cited historical
problems around the lack of robust performance man-
agement data systems, with inconsistencies in how data
were captured and communicated across the different
data systems used in the immunisation programme.
Some felt that there were on-going inconsistencies on
how data were recorded and that these issues may make
it difficult to demonstrate the effect of the Celebrate and
Protect programme.
However, direct feedback from some of the providers
suggested that the Celebrate and Protect programme
had improved uptake of immunisation:
“… we are doing a lot better than we were…imms
uptake has improved…no negative feedback from
patients or staff…” “.... percentage of children coming
in has risen … imms uptake [has increased].... our
take up for 6 week check…good…anyway…”
(Group 2-practitioners)
Whilst the responses were positive in terms of the
perceived increase in immunisation it would be diffi-
cult to attribute causality solely to the celebration
cards. There were of course also challenges to imple-
mentation that were identified, especially relating to
staffing:
“…Cards were (in a box) waiting for me when I
returned from Maternity leave” “…difficult in our
practice…” “…takes time…writing names and
address on envelope.... do not generate labels…”
(Group 2-practitioners).
Some operational challenges cited included the time
taken to generate address labels. It was also felt that the
Celebrate and Protect programme needed a lot of atten-
tion to detail for fear of missing any children:
“…fantastic but…time consuming [especially] mail
merge…have to ensure search is correct’....
one[issue]....’can miss new registrants in between
monthly searches.... uses Open Exeter…” “…takes
time…writing names and address on envelope.... do
not generate labels…” (Group 2-practitioners).
Some providers suggested expanding the remit of the
Celebrate and Protect programme to include those chil-
dren and their parents/carers not registered with a GP
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through engaging with health visitors and liaising with
maternity units to co-ordinate from birth:
“…(Celebrate and Protect) doesn’t cover new
parents/carers … they do not see us … see health
visitor…health visitors remind them but [the] call
has not come from [the] surgery so mothers
forget…” “some parents take time to register their
new-born” (Group 2-practitioners).
Acceptability
Whilst the idea of receiving celebration cards was
rated highly by all categories of respondents, less
than 10 % of the parents/carers attending the focus
group had received one. Much of their response to
the cards was framed as a comparison to more
traditional call/recall mechanisms, especially practice
letters.
“…do you see what I mean? You need to get your child
to the clinic. You need to get them immunised. This
[celebration card] is like; it is more of a positive
reinforcement. The letter is more; you have been told
off. This is more like… it is colourful…” “…good idea…
a good reminder…because you have a little baby,
sleepless nights, sometimes you might forget to make
an appointment”, “Oh, even I missed the first MMR
when he was two because I forgot, I’m involved in
health and I forgot to get him immunised…
(the card would have) without a doubt (helped)…”
(Group 3-parents/carers).
This was echoed by the providers who felt it was more
acceptable to send celebration cards, as it would en-
hance the call/recall systems and improve relationships
with patients.
One particular aspect of the Celebrate and Protect
programme—working closely with a pharmaceutical
company—was seen as particularly novel but it was
recognised that this could have some inherent risks.
All categories of respondents expressed opinions re-
lated to the decision to work in collaboration with a
pharmaceutical company and most responses were
positive:
“…personally.... supportive of this stance.... embrace
new ways of working.... learn from partners....”(Group
1-policymakers); “couple of years ago…probably would
have had more reservations…but now as long as
ethical issues are covered as required by DH policy
document…we need to get used to working with private
providers” “Personally ‘don’t have an issue”, because
the “reputation of pharmaceuticals is changing”…
(Group 2-practitioners).
The financial benefits of pharmaceutical industry in-
volvement were recognised by some:
“…growing reality…cannot afford purely a PH project
as high costs.... three times costs for distribution and
procurement” “…in the new world …you want to
continue [working] with Sanofi.... they will make a
corporate social responsibility contribution....”
(Group 2-practitioners).
Others expressed concerns about how this was
represented:
“…uncomfortable territory for some…”(Group
2-practitioners); “…we.... met a lot of resistance …
whether it was appropriate to work with a
pharmaceutical company…[despite] DH guidelines
[to].... support partnership working with industry….
[there is] local level resistance to engaging with
this philosophy…” (Group 1-policymakers).
Asked on their views about the NHS working with a
pharmaceutical company, parents/carers were generally
accepting of the concept provided that necessary ap-
provals and authorisations were undertaken:
“…If the NHS have approved, then I am okay with
it…” (Group 3-parents/carers).
Others however were quite sceptical in view of previ-
ously televised broadcasts on unethical activities by some
pharmaceutical companies:
“…I saw on the telly about price fixing with
pharmaceutical companies, where they offer GPs
incentives to prescribe their product....”
(Group 3-parents/carers).
Despite this suggestion, the aim of the Celebrate and
Protect programme was primarily to increase vaccination
and to improve relationships between parents/carers and
primary care practices. Parents/carers identified with this
aspect of the programme:
“… (it would make one) feel warmer towards your GP
surgery”, “…If you received a card from GP you would
feel cared for…” (Group 3-parents/carers)
However, this was not shared by all:
“No. I don’t think it would make a difference for me
because my practice is always grumpy. I don’t think
it’ll change that” (Group 3-parents/carers).
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Discussion
The Celebrate and Protect programme has demonstrated
innovative partnership working bringing together stra-
tegic leads from the NHS and local government along-
side partners from the pharmaceutical industry, Sanofi
Pasteur MSD. The celebration card, which formed the
main intervention delivered within the programme, was
co-designed with parents/carers, who were able to influ-
ence the design and content of the card, providing some
insight about why parents/carers may or may not choose
to have their children immunised.
Whilst this analysis did aim to assess the effectiveness
of the Celebrate and protect programme in improving
vaccination rates amongst different typologies of par-
ents/carers, the programme is unlikely to have any sig-
nificant effect on vaccine ‘rejecters’ and most likely to
impact ‘vaccine hesitant’ parents/carers [10]. Further-
more, whilst the evaluation did not specifically assess
the impact of ethnic and cultural background, there was
some attempt at cultural inclusivity with information be-
ing provided in a number of languages, which again may
support inclusion of BME communities, although makes
no explicit attempts to address some of the more com-
plex underlying issues [15]. In addition, there was a
strong association between the cards and the city of
London, through the use of identifiable landmarks, and
many of the images were representative of the links with
the London 2012 Olympics, which could be seen as a
globally inclusive event. Furthermore inner city areas
with high density, deprived populations have been
shown to have particularly low rates of MMR uptake
and have been identified as requiring specific interven-
tions to improve vaccination uptake.
Suitability, feasibility and acceptability
The Feasibility, Suitability and Acceptability framework
is used to assess the relative success or failure of a stra-
tegic option.
Following the qualitative evaluation, it would seem
that the Celebrate and Protect programme could be
judged as a low risk and low cost strategy that could be
delivered feasibly within the resources and competencies
that were available during wave one, although significant
organisational and structural changes have occurred
since then. The specific intervention (i.e. the celebration
card and vaccine schedule) used within the programme
has been shown to be suitable for achieving the objec-
tives of the programme, although demonstrating the ef-
fectiveness of the intervention in terms of its impact on
vaccination uptake remains a challenge. Whilst the inter-
vention has been shown to be acceptable both to those
delivering it (i.e. primary care staff ) and to the intended
recipients (i.e. parents/carers of children under the age
of 5), a number of recommendations were identified
from the focus groups that resulted in changes to the
intervention for subsequent waves. This iterative devel-
opment demonstrates the flexibility and adaptability of
the celebration card.
Acceptability of the programme at a strategic level was
demonstrated throughout the evaluation, although due
to the structural reorganisation of the NHS and changes
in the roles and responsibilities of those initially involved
in the programme, it should be recognised that there are
important risks in terms of managing the relationships
crucial to the feasibility of the Celebrate and Protect
programme in the longer term.
Collaboration with industry
Collaboration with ‘industry’ can provide economies of
scale along with strategic expertise and an in-depth un-
derstanding of logistics, which were fundamental to the
delivery of the Celebrate and Protect programme. In
addition it was observed that an important role of the
industry partner, especially during the time of NHS tran-
sition experienced during the programme, was the
consistency and continuity offered to the programme.
As the Celebrate and Protect programme was initiated
in conjunction with the industry partner, a unique col-
laborative framework was provided through which many
different organisations voluntarily co-operated to de-
velop a ‘bottom-up’ potential solution to an intractable
problem. This benefit of course needs to be measured
against any potential conflicts of interest that may be
represented by such collaborations. In this case, as child-
hood vaccine is procured nationally through a tendering
process involving multiple pharmaceutical companies,
there appears to be no immediate conflict of interest in
working with SPMSD given that the partnership abides
by the DH/Association of British Pharmaceutical Indus-
tries Framework on partnership with pharmaceutical
companies [18].
Limitations
Whilst the sampling strategy identified a broad range of
parents/carers, for pragmatic reasons it did not specific-
ally target the intended beneficiaries of the Celebrate
and Protect programme in that the parents/carers at-
tending the focus groups were not necessarily registered
with GP practices participating in the first wave of the
programme. In addition, the recruitment of primary care
staff coincided with a busy influenza vaccination season
resulting in a lower than expected participation.
Conclusion
This paper reports on the findings of a study to assess
the feasibility, suitability and acceptability of the Celebrate
and Protect programme. The programme is innovative in
a number of ways, having been established collaboratively
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by a range of partners including PCTs, GP practices, local
authorities and a pharmaceutical company producing
childhood vaccines. It uses a novel method (the celebra-
tion card) to engage with parents and carers of children in
order to increase vaccination uptake and to improve rela-
tionships between service users and providers. The card
was designed with input from all the relevant stake-
holders, including parents/carers, and the programme was
developed iteratively, with on-going review and evaluation
so that potential improvements could be tested rapidly
and incorporated without delay.
The analysis presented here focuses on the suitability,
acceptability and feasibility of the programme, drawing
on qualitative data collected through interviews and
focus groups as part of a wider evaluation process, which
also involved a quantitative analysis of vaccination
uptake rates. The analysis identified that many of the
factors that have been proposed in the conceptual model
of vaccine acceptance/rejection are indeed important to
parents/carers [11].
From this qualitative analysis, it is clear that the cele-
bration card is suitable for purpose and acceptable both
to healthcare professionals and to parents/carers of chil-
dren. In terms of feasibility, the Celebrate and Protect
programme has thus far been able to deliver its process
aims (i.e. recruitment of practices and delivery of the
celebration cards) within the allocated resources al-
though several issues of on-going sustainability were
raised, mainly in relation to the changing primary care
infrastructure. In addition, the question of whether the
very positive views expressed about the Celebrate and
Protect programme can be linked to more quantitative
outputs and outcomes (such as vaccination uptake rates)
was not within the scope of this analysis but remains an
important line of further inquiry.
Endnotes
1As a result of the Health and Social Care Act 2012,
Primary Care Trusts ceased to exist on 31 March 2013
and were replaced by Clinical Commissioning Groups
(CCGs). In London the PCTs were broadly coterminous
with local authority boroughs and were the geographical
unit for which immunisation rates were recorded.
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